title: Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate.
abstract: 1. The human P2U-purinoceptor was stably expressed in 1321N1 human astrocytoma cells and the pharmacological selectivity of the expressed receptor was studied by measurement of inositol lipid hydrolysis. 2. High basal levels of inositol phosphates occurred in P2U-purinoceptor-expressing cells. This phenomenon was shown to be due to release of large amounts of ATP from 1321N1 cells, and could be circumvented by adoption of an assay protocol that did not involve medium changes. 3. UTP, ATP and ATP gamma S were full and potent agonists for activation of phospholipase C with EC50 values of 140 nM, 230 nM, and 1.72 microM, respectively. 5BrUTP, 2C1ATP and 8BrATP were also full agonists although less potent than their natural congeners. Little or no effect was observed with the selective P2Y-, P2X-, and P2T-purinoceptor agonists, 2MeSATP, alpha,beta-MeATP, and 2MeSADP, respectively. 4. Diadenosine tetraphosphate, Ap4A, was a surprisingly potent agonist at the expressed P2U-purinoceptor with an EC50 (720 nM) in the range of the most potent P2U-purinoceptor agonists. Ap4A may be a physiologically important activator of P2U-purinoceptors.
authors.affiliation: Department of Pharmacology, University of North Carolina, School of Medicine, Chapel Hill 27599, USA.
authors.forename: E R
authors.initials: ER
authors.lastname: Lazarowski
authors.forename: W C
authors.initials: WC
authors.lastname: Watt
authors.forename: M J
authors.initials: MJ
authors.lastname: Stutts
authors.forename: R C
authors.initials: RC
authors.lastname: Boucher
authors.forename: T K
authors.initials: TK
authors.lastname: Harden
mesh_terms: D000225:Adenine / Q000378:metabolism; D000227:Adenine Nucleotides / Q000378:metabolism; D001254:Astrocytoma / Q000235:genetics / Q000378:metabolism; D003001:Cloning, Molecular; D015226:Dinucleoside Phosphates / Q000494:pharmacology*; D006801:Humans; D007295:Inositol Phosphates / Q000378:metabolism; D058910:Purinergic P2 Receptor Agonists; D018048:Receptors, Purinergic P2 / Q000235:genetics / Q000502:physiology; D015290:Second Messenger Systems; D012680:Sensitivity and Specificity; D014162:Transfection; D014316:Tritium; D014407:Tumor Cells, Cultured; D014544:Uridine Triphosphate / Q000494:pharmacology
chemical_list: D000227:Adenine Nucleotides; D015226:Dinucleoside Phosphates; D007295:Inositol Phosphates; D058910:Purinergic P2 Receptor Agonists; D018048:Receptors, Purinergic P2; D014316:Tritium; C020733:diadenosine tetraphosphate; D000225:Adenine; D014544:Uridine Triphosphate